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Résumé en
anglais
Starting from the diterpene (4S,9R,10R) methyl 18-carboxy-labda-8,13(E)-dien-15-
oate (PMD) and its 8(9)-en isomer [PMD 8(9)-en], 11 amides were prepared and
assessed for a gastroprotective effect in the ethanol/HCl-induced gastric lesions
model in mice. Basal cytotoxicity of the compounds was determined on the
following human cell lines: normal lung fibroblasts (MRC-5), gastric epithelial
adenocarcinoma (AGS), and hepatocellular carcinoma (Hep G2). All compounds are
described for the first time. At the single oral dose of 0.1 mg/kg, compounds 1, 10,
and 11 presented a strong gastroprotective effect, at least comparable with that of
the reference compound lansoprazole at 1 mg/kg, reducing gastric lesions by 76.7,
67.7, and 77.2 %, respectively. The leucyl amide methyl ester 3, tryptophanyl amide
methyl ester 5, and benzyl amide 6 of PMD presented a selective basal cytotoxicity
on Hep G2 cells with IC50 values of 136.8, 105.3, and 94.2 µM, respectively, while
the IC50 values towards AGS cells were 439.5, 928.0, and 937.3 µM, respectively.
The three compounds did not affect fibroblast viability with IC50 values > 1000 µM.
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